Shares of Evofem Biosciences, Inc. (NASDAQ:EVFM – Get Free Report) crossed below its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of $0.01 and traded as low as $0.0090. Evofem Biosciences shares last traded at $0.0091, with a volume of 75,055 shares traded.
Evofem Biosciences Stock Performance
The business’s 50 day moving average price is $0.01 and its 200-day moving average price is $0.01. The firm has a market capitalization of $1.15 million, a PE ratio of -0.01 and a beta of -1.41.
About Evofem Biosciences
Evofem Biosciences is a clinical‐stage biotechnology company based in San Diego, California, specializing in women’s sexual and reproductive health. Founded in 2013 as a spin-out of the Scripps Research Institute, the company is focused on developing non-hormonal, on-demand products that address unmet needs in contraception and the prevention of sexually transmitted infections.
The company’s lead commercial product, Phexxi, is an FDA-approved, non-hormonal vaginal gel that maintains the vagina’s natural pH to reduce the risk of unintended pregnancy.
Featured Stories
- Five stocks we like better than Evofem Biosciences
- The gold chart Wall Street is terrified of…
- America’s 1776 happening again
- Buy this Gold Stock Before May 2026
- What a Former CIA Agent Knows About the Coming Collapse
- “Fed Proof” Your Bank Account with THESE 4 Simple Steps
Receive News & Ratings for Evofem Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Evofem Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.
